Lupus Trial, Recruiting NCT07666711 Sponsor: Oslo University Hospital Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT07666711
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with systemic lupus erythematosus (lupus/SLE) based on recognised medical criteria
  • You are already receiving regular medical care at Oslo University Hospital or another centre taking part in this trial
  • You are able to understand and agree to take part by signing a consent form
  • You are willing and able to provide blood and/or urine samples for testing
  • For one specific part of the trial (biopsy validation): your blood or urine test results have shown certain changes or ongoing raised levels that suggest your kidneys may be affected, and your doctor suspects possible kidney involvement or is uncertain about kidney activity based on your test results

Who may not be able to join:

  • You are unable to give your agreement to take part, unless there is an approved alternative way to handle consent
  • You have a kidney condition that is not related to lupus, which could make it hard to correctly interpret your test results
  • You have had a kidney transplant in the past
  • You currently have an active infection or a serious sudden illness that could affect the study procedures or how your test results are understood
  • For the biopsy validation part only: your doctor has decided that having a kidney biopsy would not be safe or appropriate for you
  • For the biopsy validation part only: there is a medical reason why you should not have a kidney biopsy, based on your hospital's guidelines or your specialist's assessment (confirm with trial site)
  • For the biopsy validation part only: you do not wish to have a kidney biopsy or do not want to take part in the biopsy validation part of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Simin Jamaly, PhD, Oslo University Hospital

Phone: +4746949074

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 June 2026
Est. completion
14 June 2031

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Area Under the Receiver Operating Characteristic Curve of the Combined Blood-and-Urine Biomarker Score for Active Lupus Nephritis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov